COO
$228.45
Cooper Companies
$1.89
.83%
COO
Earnings Whisper ®
N/A
1st Quarter January 2018
Consensus:  $2.49
Revenue:  N/A
Thursday
Mar 8
4:15 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Thursday, December 07, 2017

What do you expect when COO reports earnings?
Beat
Meet
Miss

Where is COO's stock price going from here?
Up
Flat
Down
Stock chart of COO
Analysts
Summary of analysts' recommendations for COO
Score
Grade
Pivots
Resistance
$232.50
$230.74
$229.59

$227.83

Support
$226.68
$224.92
$223.77
Tweet
Growth
Description
The Cooper Companies, Inc., through its principal subsidiaries, develops, manufactures and markets healthcare products. CooperVision markets a range of contact lenses to correct visual defects, specializing in toric lenses that correct astigmatism. The company also markets conventional toric and spherical lenses and lenses for patients with more complex vision disorders. CooperSurgical markets diagnostic products, surgical instruments and accessories to the women's healthcare market.
Peers
Staar Surgical